Linda C. Hogan is Head & Bus. Dev. and Strategy at CoLucid Pharmaceuticals, Inc. (CLCD). They have made 7 open-market trades across 1 company since 2016, most recently 2017-01-05.
CIK 0001348649
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLCD | 1,200 | $56K |
Shares reported on the most recent Form 4, priced at the 2017-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLCD | SELL | 2017-01-03 | 2017-01-05 | $35.04 | $128K | +39.9% | +40.4% | N/A |
| CLCD | SELL | 2016-12-05 | 2016-12-05 | $38.75 | $65K | -7.4% | -10.8% | N/A |
| CLCD | SELL | 2016-12-01 | 2016-12-05 | $37.21 | $123K | -7.4% | -10.8% | N/A |
| CLCD | SELL · 10b5-1 | 2016-11-04 | 2016-11-07 | $28.56 | $53K | +29.4% | +37.0% | +60.3% |
| CLCD | SELL · 10b5-1 | 2016-11-01 | 2016-11-01 | $30.00 | $22K | +11.6% | +14.7% | +46.8% |
| CLCD | SELL | 2016-10-05 | 2016-10-05 | $37.08 | $62K | -6.7% | -21.1% | -0.8% |
| CLCD | SELL | 2016-10-03 | 2016-10-05 | $37.22 | $96K | -6.7% | -21.1% | -0.8% |
| CLCD | SELL | 2016-09-06 | 2016-09-07 | $19.87 | $969K | +51.0% | +81.2% | +101.8% |
| CLCD | SELL | 2016-09-06 | 2016-09-07 | $19.86 | $868K | +51.0% | +81.2% | +101.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.